Kelm Jens M, Djonov Valentin, Ittner Lars M, Fluri David, Born Walter, Hoerstrup Simon P, Fussenegger Martin
Institute for Chemical and Bio-Engineering, Swiss Federal Institute of Technology, Zurich, Switzerland.
Tissue Eng. 2006 Aug;12(8):2151-60. doi: 10.1089/ten.2006.12.2151.
Tissue engineering strategies are gathering clinical momentum in regenerative medicine and are expected to provide excellent opportunities for therapy for difficult-to-treat human pathologies. Being aware of the requirement to produce larger artificial tissue implants for clinical applications, we used microtissues, produced using gravity-enforced self-assembly of monodispersed primary cells, as minimal tissue units to generate scaffold-free vascularized artificial macrotissues in custom-shaped agarose molds. Mouse myoblast, pig and human articular-derived chondrocytes, and human myofibroblast (HMF)-composed microtissues (microm3 scale) were amalgamated to form coherent macrotissue patches (mm3 scale) of a desired shape. Macrotissues, assembled from the human umbilical vein endothelial cell (HUVEC)-coated HMF microtissues, developed a vascular system, which functionally connected to the chicken embryo's vasculature after implantation. The design of scaffold-free vascularized macrotissues is a first step toward the scale-up and production of artificial tissue implants for future tissue engineering initiatives.
组织工程策略在再生医学领域正逐渐获得临床应用的动力,有望为治疗难治性人类疾病提供绝佳的治疗机会。鉴于临床应用需要生产更大的人工组织植入物,我们使用通过单分散原代细胞重力驱动自组装产生的微组织作为最小组织单元,在定制形状的琼脂糖模具中生成无支架的血管化人工大组织。将小鼠成肌细胞、猪和人关节来源的软骨细胞以及人肌成纤维细胞(HMF)组成的微组织(微米³ 尺度)合并,形成所需形状的连贯大组织贴片(毫米³ 尺度)。由人脐静脉内皮细胞(HUVEC)包被的HMF微组织组装而成的大组织形成了一个血管系统,植入后该血管系统与鸡胚的脉管系统建立了功能连接。无支架血管化大组织的设计是未来组织工程计划中人工组织植入物扩大规模和生产的第一步。